格列卫治疗老年慢性粒细胞白血病的临床疗效观察  

Clinical effects of gleevc on aged chronic myeloid leukemia

作　　者：王艳玲[1] 杨尚波[2] 刘占凤[3] 杜志刚[1] 刘海涛[1] 张嵩[1] 高峰[4] 朱梦波[4] 

机构地区：[1]华北煤炭医学院附属医院血液内科,河北唐山063000 [2]唐山市第四医院 [3]华北煤炭医学院临床医学系,河北唐山063000 [4]唐山钢铁集团医院

出　　处：《华北煤炭医学院学报》2007年第2期150-151,共2页Journal of North China Coal Medical College

摘　　要：①目的探讨格列卫对老年慢性粒细胞白血病(慢性期,CML-CP)的疗效;②方法6例CML-CP老年患者采用格列卫400mg/d,饭后1次口服,30天为1个疗程,随症处理;③结果6例患者完全缓解,总有效率100%;④结论格列卫治疗CML-CP有显效,且反应快,毒副作用也小,是自体干细胞移植前患者的一线治疗方法。Objective To evaluate the effects of treatment of Gleevec on the old patients with chronic myeloid leukemia in chronic phase(CML-CP).Methods 6 CML-CP patients were respectively treated with 400mg/d Gleevec for 30 days,oral medications after meal.Resuits All 6 patients achieved complete remission and the effective rate was 100%.Conclusion The roles of Gleevec are fast and its adverse effects are mild in the treatment of CML.Gleevec is the best treatment before autogeneic prepherial blood stem cells transplantation.

关 键 词：粒细胞白血病/慢性期 格列卫 老年人 

分 类 号：R557[医药卫生—血液循环系统疾病]